ReviewAdvances in therapy2022

Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?

Mário Fontes-Sousa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.